MedPath

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

Not Applicable
Recruiting
Conditions
Visual Field Defect, Peripheral
Interventions
Device: VisuALL
Device: Humphrey Visual Field
Registration Number
NCT05150197
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test.

The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants.

Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients must be at least four (4) years old
  • Cognitively normal (no developmental delay or syndrome)
  • Be able to tolerate wearing the virtual reality goggles for at least 10 minutes
  • Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)
  • Do not have any ocular diseases that could interfere with the visual field testing
Exclusion Criteria
  • Developmental delay
  • Inability to obtain consent
  • Inability to understand English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupVisuALLThis group will only perform the VisuALL Virtual Reality Visual Field.
Patient (pathology) groupHumphrey Visual FieldThis group will perform both the standard of care Humphrey Visual Field (HVF) and the VisuALL Virtual Reality Visual Field.
Patient (pathology) groupVisuALLThis group will perform both the standard of care Humphrey Visual Field (HVF) and the VisuALL Virtual Reality Visual Field.
Primary Outcome Measures
NameTimeMethod
Mean deviation results of visual field parametersDuring office visit, approximately 30 minutes

Mean deviation of the visual field is one score measured in decibels calculated from device reading

Pattern standard deviation results of visual field parametersDuring office visit, approximately 30 minutes

Pattern standard deviation of the visual field is one score calculated from device reading

Sensitivity results of visual field parametersDuring office visit, approximately 30 minutes

Sensitivities are the results of each space in the visual field measured in decibels

Secondary Outcome Measures
NameTimeMethod
Percent of patients able to use VisuALL in-office testing as measured by patient observationDuring office visit, approximately 30 minutes
Percent of participants stating satisfaction as measured by questionnaireDuring office visit, approximately 5 minutes

12 questions with strongly disagree to strongly agree

Percent of times that scotomas were visualized as measured by visual field testsDuring office visit, approximately 30 minutes
Percent of patients able to use VisuALL home testing as measured by device readingOne month, 1-2 tests per week

Home testing will be done in a few patients that demonstrate facility with device

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath